摘要 |
The present invention relates to novel biologically-active glutarimide derivatives of general formula (I) or pharmaceutically acceptable salts thereof, and to the application thereof as means for treating eosinophilic diseases of a predominantly allergic nature, and specifically, bronchial asthma, allergic rhinitis, polypoid rhinosinusitis, eosinophilic colitis, eosinophilic syndrome, allergic conjunctivitis, atopic dermatitis, Churg-Strauss syndrome, anaphylactic shock, Quincke's edema, eosinophilic vasculitis, eosinophilic esophagitis, eosinophilic gastroenteritis and fibrosis, and relates to pharmaceutical compositions containing glutarimide derivatives of general formula (I). |